Stimart Tryn 4
4 · AbCellera Biologics Inc. · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Stimart Tryn
Chief Legal Officer
Transactions
- Award
Share Options (right to buy)
2022-12-01+346,901→ 2,658,381 totalExercise: $13.18Exp: 2032-12-01→ Common Shares (346,901 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.